Image

Phase 3 Accelerated BEP Trial: A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours

Study of Accelerated vs. Standard Chemotherapy for Metastatic Germ Cell Tumors

Recruiting
11-45 years
All
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates the effectiveness of an accelerated chemotherapy regimen compared to the standard regimen for treating metastatic germ cell tumors (GCTs). Germ cell tumors are a type of cancer that begins in the cells that form sperm or eggs. The study aims to see if the accelerated treatment is more effective without being more toxic than the standard treatment.

Participants will be randomly assigned to one of two study arms. One arm will receive the accelerated chemotherapy regimen, while the other will receive the standard regimen. Chemotherapy involves using drugs to kill cancer cells, and the study will monitor the effectiveness and side effects of each treatment.

  • Who can participate: Participants must be between 11 and 45 years old. They must have a confirmed diagnosis of germ cell tumor or certain high tumor marker levels indicating GCT.
  • Study details: Participants will be assigned to either an accelerated or standard chemotherapy regimen. The study will compare the effectiveness and side effects of the two regimens.
Print
Study details
    Germ Cell Tumor

TX10204

19 February 2024

Contact a study center
Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact label
Please provide your preferred way of contact1234
Other language

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.